In focus · trending topic

drug development programs

2 stories · following the connections

MolecularMD to Implement Promega’s Microsatellite Instability (MSI) Technology for Immuno-Oncology Applications

By Nasdaq OMXNov 14, 2017, 1:00 AM UTC

MolecularMD Announces Partnership with Indica Labs to Support Improved Clinical Trial Histopathology Workflows Integrating Digital Biomarker Analysis Services

By Nasdaq OMXSep 29, 2017, 12:00 AM UTC